MARKER THERAPEUTICS, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
MARKER THERAPEUTICS, INC. (MRKR) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $0 as of 2020-12-31, per its 10-K filed 2021-03-09.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2021-03-09
- 2020-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $0.00.
- 2020-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $0.00.
- 2020-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $0.00.
- 2020-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $0.00.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-09 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-09 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-10 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-11 |
| 2019-12-31 | $31.00K 10-K · filed 2021-03-09 |
| 2019-09-30 | $129.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $65.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $58.00K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $49.00K 10-K · filed 2021-03-09 |
| 2018-09-30 | $107.00K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $147.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $8.00K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $9.00K 10-K · filed 2020-03-12 |
| 2017-09-30 | $6.00K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $10.00K 10-Q · filed 2017-08-07 |
| 2017-03-31 | $17.50K 10-Q · filed 2017-05-05 |
| 2016-12-31 | $14.50K 10-K · filed 2019-03-15 |
| 2016-09-30 | $29.00K 10-Q · filed 2016-11-04 |
| 2015-12-31 | $26.49M 10-K · filed 2018-03-23 |
| 2014-12-31 | $9.00K 10-K · filed 2017-03-14 |
| 2012-06-30 | $894.64K 10-Q/A · filed 2012-09-12 |
| 2011-12-31 | $1.32M 10-Q/A · filed 2012-09-12 |
| 2010-12-31 | $1.99M 10-Q/A · filed 2012-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |